Gerber et al developed an algorithm for managing venous thromboembolism in a patient with a primary or metastatic brain tumor. This can help balance risks and benefits of the possible interventions in these patients. The authors are from Johns Hopkins University in Baltimore.
Patient selection:
(1) primary or metastatic brain tumor
(2) presence of venous thromboembolism
Indications for placement of a filter in the inferior vena cava (IVC):
(1) craniotomy within the past 3 to 5 days
(2) brain metastates due to malignant melanoma, renal cell carcinoma, choriocarcinoma, or thyroid cancer (relative contraindications to anticoagulation therapy)
(3) contraindications to anticoagulation
(4) evidence of recent bleeding on a noncontrast head CT
If an IVC filter is not placed for these reasons, then the patient is evaluated for (1) signs and symptoms of acute or progressive venous thromboembolism and (2) ability to tolerate anticoagulation for 24 hours or longer.
Signs Progressive VTE |
Tolerate Anticoagulation |
Therapy |
severe |
yes |
IV heparin with full bolus; start long term anticoagulation |
severe |
no |
IV heparin with full bolus; place IVC filter |
moderate |
yes |
IV heparin with mini bolus; start long term anticoagulation |
moderate |
no |
IV heparin with mini bolus; place IVC filter |
no |
yes |
IV heparin without bolus; start long term anticoagulation |
no |
no |
IV heparin without bolus; place IVC filter |
Specialty: Hematology Oncology, Clinical Laboratory
ICD-10: ,